Biological Sciences Division
Published October 6, 2016 | Version v1
Patent Open

USE OF STING AGONIST AS CANCER TREATMENT

Creators

  • 1. University of Chicago

Contributors

Description

Methods and compositions for treating cancer by intratumorally administering a stimulator of interferon genes (STING) agonist are disclosed herein. In some embodiments, there are provided compositions and methods concerning methods for treating cancer in a subject comprising administering to the subject an effective amount of a stimulator of interferon genes (STING) agonist, wherein the STING agonist is administered intratumorally.

Files

US20160287623.pdf

Files (3.4 MB)

Name Size Download all
md5:5031b8117906159ce02137f0700bfdc5
3.4 MB Preview Download

Additional details

Identifiers

Patent application number
US 201415035432 A
Patent number
US 2016/0287623 A1
Other
oai:uchicago.tind.io:9463

Dates

Patent filed
2014-11-19

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology, Medicine